Hutchmed (China) Limited Director's Share Dealing (2733S)
08 Mars 2023 - 9:30AM
UK Regulatory
TIDMHCM
RNS Number : 2733S
Hutchmed (China) Limited
08 March 2023
Director's Share Dealing
Hong Kong, Shanghai & Florham Park, NJ - Wednesday, March 8,
2023: HUTCHMED (China) Limited (" HUTCHMED " or the "Company")
(Nasdaq/AIM: HCM; SEHK:13) has received notifications that Mr
Johnny Cheng, Executive Director and Chief Financial Officer, sold
a total of 1,300,000 Ordinary Shares of US$0.10 each of the Company
at an average price of HK$27.073 per Ordinary Shares on March 3,
2023 and March 6, 2023.
Following the above sale of 1,300,000 Ordinary Shares, the
holding of Mr Cheng is 1,261,460 Ordinary Shares and 274,493 ADSs
(Note) , representing approximately 0.3% of the current issued
share capital of the Company.
Note: 274,493 ADSs included (i) 41,552 ADSs currently held by Mr
Cheng, (ii) 217,800 ADSs granted under Share Option Scheme and
(iii) 15,141 ADSs as beneficiary of a trust under long term
incentive plan.
The notifications set out below are provided in accordance with
the requirements of the EU Market Abuse Regulation.
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Mr Johnny Cheng
--------------------------------------- -------------------------------------------------------------------
2 Reason for the notification
------------------------------------------------------------------------------------------------------------
a) Position/status Executive Director and Chief Financial Officer
--------------------------------------- -------------------------------------------------------------------
b) Initial notification/Amendment Initial notification
--------------------------------------- -------------------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
------------------------------------------------------------------------------------------------------------
a) Name HUTCHMED (China) Limited
--------------------------------------- -------------------------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
--------------------------------------- -------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
------------------------------------------------------------------------------------------------------------
a) Description of the financial Ordinary Shares of US$0.10 each
instrument, type of instrument
Identification code DI ISIN: KYG4672N1198
--------------------------------------- -------------------------------------------------------------------
b) Nature of the transaction Sale of 830,000 Ordinary Shares on March 3, 2023 at an average
price of HK$27.101.
--------------------------------------- -------------------------------------------------------------------
Price(s) Volume(s)
------------------------- --------------------------------------
HK$26.850 50,000 Ordinary Shares
------------------------- --------------------------------------
HK$26.950 20,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.000 110,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.005 50,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.015 20,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.016 40,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.027 30,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.050 10,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.091 200,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.100 50,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.113 100,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.150 20,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.200 30,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.300 40,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.450 10,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.500 20,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.656 20,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.700 10,000 Ordinary Shares
------------------------- --------------------------------------
c) Price(s) and volume(s)
--------------------------------------- ------------------------- --------------------------------------
d) Aggregated information Aggregated volume: 830,000 Ordinary Shares
- Aggregated volume Price information: HK$22,494,120
- Price
--------------------------------------- -------------------------------------------------------------------
e) Date of the transaction 2023-03-03
--------------------------------------- -------------------------------------------------------------------
f) Place of the transaction Hong Kong Stock Exchange
--------------------------------------- -------------------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
------------------------------------------------------------------------------------------------------------
a) Description of the financial Ordinary Shares of US$0.10 each
instrument, type of instrument
Identification code DI ISIN: KYG4672N1198
--------------------------------------- -------------------------------------------------------------------
b) Nature of the transaction Sale of 470,000 Ordinary Shares on March 6, 2023 at an average
price of HK$27.022.
--------------------------------------- -------------------------------------------------------------------
Price(s) Volume(s)
------------------------- --------------------------------------
HK$26.850 30,000 Ordinary Shares
------------------------- --------------------------------------
HK$26.900 10,000 Ordinary Shares
------------------------- --------------------------------------
HK$26.908 10,000 Ordinary Shares
------------------------- --------------------------------------
HK$26.950 70,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.000 50,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.050 68,500 Ordinary Shares
------------------------- --------------------------------------
HK$27.060 200,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.100 20,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.250 10,000 Ordinary Shares
------------------------- --------------------------------------
HK$27.300 1,500 Ordinary Shares
------------------------- --------------------------------------
c) Price(s) and volume(s)
--------------------------------------- ------------------------- --------------------------------------
d) Aggregated information Aggregated volume: 470,000 Ordinary Shares
- Aggregated volume Price information: HK$12,700,455
- Price
--------------------------------------- -------------------------------------------------------------------
e) Date of the transaction 2023-03-06
--------------------------------------- -------------------------------------------------------------------
f) Place of the transaction Hong Kong Stock Exchange
--------------------------------------- -------------------------------------------------------------------
About HUTCHMED
HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative,
commercial-stage, biopharmaceutical company. It is committed to the
discovery and global development and commercialization of targeted
therapies and immunotherapies for the treatment of cancer and
immunological diseases. It has more than 5,000 personnel across all
its companies, at the center of which is a team of about 1,800 in
oncology/immunology. Since inception, HUTCHMED has focused on
bringing cancer drug candidates from in-house discovery to patients
around the world, with its first three oncology drugs now approved
and marketed in China. For more information, please visit:
www.hutch--med.com or follow us on LinkedIn.
Contacts
Investor Enquiries
Mark Lee, Senior Vice President +852 2121 8200
Annie Cheng, Vice President +1 (973) 306 4490
Media Enquiries
Americas - Brad Miles, Solebury Trout +1 (917) 570 7340 (Mobile)
bmiles@soleburystrat.com
Europe - Ben Atwell / Alex Shaw, FTI Consulting +44 20 3727 1030 / +44 7771 913 902 (Mobile) / +44 7779 545 055
(Mobile)
HUTCHMED@fticonsulting.com
Asia - Zhou Yi, Brunswick +852 9783 6894 (Mobile)
HUTCHMED@brunswickgroup.com
Nominated Advisor
Atholl Tweedie / Freddy Crossley,
Panmure Gordon (UK) Limited +44 (20) 7886 2500
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHNKFBDOBKKDNK
(END) Dow Jones Newswires
March 08, 2023 03:30 ET (08:30 GMT)
Hutchison China Meditech (LSE:0J7G)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025
Hutchison China Meditech (LSE:0J7G)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025
